Month: June 2024

The First of its Kind Vitamin-Packed, Wellness Beverage Brand Continues to Amplify its In-Store Availability Nationwide JUPITER, FL, June 06, 2024 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today its partnership with Capital Drugs as the brand expands its nationwide availability. Making strides in connecting the brand to its overarching wellness purpose, Safety Shot will be available in all 300 of the drugstore chain’s pharmacies across the United States. Entering a key market for Safety Shot consumers, Capital Drugs is known for providing a wide range of pharmaceutical services and products tailored to specific health and wellness needs. Capital Drugs offers traditional pharmacy and clinical services in tandem with alternative medicine options such as supplements, vitamins, and homeopathic products. “Entering...

Oslo, 6 June 2024 | Vow ASA (OSE: VOW) is pleased to invite shareholders, investors, analysts, and other interested parties to a Cruise special investor seminar. When: Tuesday 11 June at 10:00-11:30 CEST Where: Haakon VIIs gate 2, OsloThe session will be streamed online Vow was recently awarded its largest contract to date in cruise (see announcement on 31 May). The award signifies a new era in wastewater and waste treatment systems at sea. It confirms the relevance of Scanship technology as cruise companies are intensifying their efforts and shift towards even more environmental and sustainable operations. “We now proudly confirm that this recent contract was for newbuilds ordered by Carnival Cruise Lines, the flagship brand of Carnival Corporation and a forward-looking leader in the industry,” said Henrik Badin, CEO of Vow ASA. Vow’s...

Mama’s Creations, Inc.New Products and Flavors at IDDBA 2024Breakfast Wraps, Grilled Chicken Breast in Vacuum Packs, Meatball Entertaining Sleeves, and Paninis to Launch at Industry’s Most Significant Event EAST RUTHERFORD, NJ, June 06, 2024 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced the launch of an expanded offering of products and flavors at IDDBA 2024, which serve to cement our positioning as a true one-stop-shop for our Deli partners. The International Dairy Deli Bakery Association (IDDBA) is a nonprofit trade association for food retailers, manufacturers, wholesalers, brokers, distributors, and other industry professionals. The IDDBA annual tradeshow – taking place June 9-11, 2024 in Houston, Texas – attracts...

UPM-Kymmene Corporation        Stock Exchange Release (Changes board/management/auditors)        6 June 2024 at 15:30 EEST Change in UPM’s Group Executive Team Mika Kekki assumes interim role leading UPM Communication Papers business area as of 1 August 2024 Mika Kekki has been appointed to act as interim Executive Vice President of UPM Communication Papers business area as of 1 August 2024. He assumes this role on top of his current duties and continues in his current role as Executive Vice President of UPM Plywood business area. Mika Kekki’s biographical details are available at the company’s website. The recruitment process for the Executive Vice President of UPM Communication Papers business area is ongoing. As communicated on 13 March 2024, Antti Jääskeläinen, the current interim Executive Vice President of UPM Communication Papers...

Josep CatllàEVP, Chief Corporate Affairs OfficerPARIS, FRANCE, 06 June 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Josep Catllà as EVP, Chief Corporate Affairs Officer, effective August 19, 2024. He will serve on the Executive Leadership Team (ELT) and report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “We are thrilled to welcome Josep to Ipsen as our new Chief Corporate Affairs Officer, as h. He brings years of experience inof communications and public affairs and a proven track record of developing corporate affairs leaders. His focus on patient care and sustainability and his strategic vision will be instrumental to fosterin fostering employee engagement and partnership with stakeholders while reinforcing Ipsen’s...

SYDNEY, June 06, 2024 (GLOBE NEWSWIRE) — IREN (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today published a monthly investor update for May 2024. Key HighlightsBitcoin Mining230 Bitcoin mined in May 10 EH/s operating 20 EH/s in 3Q, 30 EH/s in 4QAI Cloud Services816 NVIDIA H100 GPUs Currently servicing Poolside AI and on-demand customersData Centers260MW operating, 510MW in 2024 Childress Phase 2 & 3 construction progressing to scheduleCorporate$322m cash, no debt1 3Q FY24 results, replay hereKey Metrics May-24 Apr-24 Mar-24Bitcoin Mining2      Average operating hashrate (PH/s) 9,414 8,238 7,107Renewable energy usage (MW)3 246 220 195Bitcoin mined 230 358 353Mining...

Nexans finalizes expansion of world-class subsea cable facility in Norway to address global demand _PRESS RELEASE_Nexans has officially opened the newly expanded section of its high voltage subsea cable plant in Halden, Norway to support the increased demand globally for electrification and the energy transition. Nexans’ investment created more than 100 jobs and will be able to deliver 525kV HVDC and 420kV HVAC subsea cables. The plant incorporates the most advanced cable production technology to date and features a second extrusion tower which will allow the plant to insulate four cables simultaneously in addition to the two existing lines – the tallest building in Norway and the country’s first skyscraper. The Halden plant also celebrates its 50th anniversary, marking a key milestone in Nexans’ 109 year history in Norway.Halden,...

Pentavere’s partnership with Takeda to pioneer real-world evidence analysis for HAE patients, addressing critical gaps in treatment understanding. This innovative research collaboration has generated one of the largest cohort data sets globally of HAE with normal C1 inhibitor and will be utilized in enhancing patient outcomes through better understanding of current treatment use and clinical outcomes. This partnership and commercial engagement builds upon Pentavere winning the Takeda Canada Innovation Challenge to accelerate rare disease diagnosis and care using new AI technology that was announced in May 2022. The Canadian Organization of Rare Disorders celebrates this application of data science and analytics to patient data analysis and the public-private partnership as ground-breaking with potential to revolutionize diagnosis and...